Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series()

BACKGROUND: Chemotherapy-resistant cancer stem cells (CSC) may lead to tumor recurrence in glioblastoma (GBM). The poor prognosis of this disease emphasizes the critical need for developing a treatment stratification system to improve outcomes through personalized medicine. METHODS: We present a cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjan, Tulika, Howard, Candace M., Yu, Alexander, Xu, Linda, Aziz, Khaled, Jho, David, Leonardo, Jodi, Hameed, Muhammad A., Karlovits, Stephen M., Wegner, Rodney E., Fuhrer, Russell, Lirette, Seth T., Denning, Krista L., Valluri, Jagan, Claudio, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078520/
https://www.ncbi.nlm.nih.gov/pubmed/32197147
http://dx.doi.org/10.1016/j.tranon.2020.100755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078520/
https://www.ncbi.nlm.nih.gov/pubmed/32197147
http://dx.doi.org/10.1016/j.tranon.2020.100755

Ejemplares similares